Arkolith/Insider Trading/CHRO/Form 4

Francis Knuettel II

CEO, Pres., CFO Treas & SectyChromocell Therapeutics Corp (CHRO) · full profile →Form 4 · filed Jul 2, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 28, 2024Gift(G)5K—$0531K
Jun 28, 2024Gift(G)15K—$0516K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-24-001211) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML